Theravance (THRX)

Add to Watchlists Create an Alert
18.53 +0.08  +0.43% NASDAQ Sep 17, 3:35PM BATS Real time Currency in USD
View Full Chart
THRX Price Chart
View All Events

THRX Events

Date Type Description
08/26/2014 Dividends Amount: 0.25, Declared Date: Aug 06 2014, Pay Date: Sep 18 2014
08/06/2014 17:30 EDT Misc Q2 2014 Theravance, Inc. Earnings Conference Call
08/06/2014 Earnings Q2 2014 Theravance, Inc. Earnings Results
06/03/2014 Spinoffs Ratio: 6207:5000
05/06/2014 17:00 EDT Misc Q1 2014 Theravance, Inc. Earnings Conference Call
05/06/2014 Earnings Q1 2014 Theravance, Inc. Earnings Results
04/01/2014 Misc Theravance Appoints Kevin Kwok, Head of Talent Acquisition and Strategy
02/06/2014 05:00 EST Misc Theravance to Report Fourth Quarter and Full Year 2013 Conference Call
02/06/2014 Earnings Theravance to Report Fourth Quarter and Full Year 2013 Financial Results
10/24/2013 17:00 EDT Misc Theravance Third Quarter 2013 Financial Results Conference Call
View All Performance Charts

THRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Theravance is down 43.73% over the last year vs S&P 500 Total Return up 20.53%, Theravance Biopharma up N/A, and GlaxoSmithKline down 3.48%.

Get Quote for

PDF Report for THRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download THRX Pro Report PDF
Advertisement

Portfolio Strategies Featuring THRX

Did Theravance make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

THRX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.theravance.com
  • IR Website: http://investor.theravance.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Theravance Inc., is a biopharmaceutical company with a pipeline of internally discovered product candidates and collaborations with pharmaceutical companies.

THRX Excel Add-In Codes

  • Name: =YCI("THRX","name")
  • Description: =YCI("THRX","description")
  • Sector: =YCI("THRX","sector")
  • Industry: =YCI("THRX","industry")
  • Est. Current Fiscal Year End: =YCI("THRX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.